Chemokine receptors and their interactors in HIV-1 replication: potential therapeutic targets
Author(s) -
Chuang Li,
Yijie Zhang,
Denis J. Dupré,
YiQun Kuang
Publication year - 2015
Publication title -
receptors and clinical investigation
Language(s) - English
Resource type - Journals
ISSN - 2330-0566
DOI - 10.14800/rci.1016
Subject(s) - replication (statistics) , human immunodeficiency virus (hiv) , virology , chemokine receptor , receptor , biology , computational biology , chemokine , genetics
Chemokine receptors CXCR4 and CCR5 are co-receptors indispensable for human immunodeficiency virus type 1 (HIV-1) entry and subsequent infection in host cells. Antiretroviral therapies based on the viral proteins have been developed, and significant achievements have been made in the treatment of HIV/AIDS patients based on the HAART regimens. However, a lot of concerns are still present, the purge of latent viral reservoirs and cure of AIDS are currently impossible, and prophylactic vaccines are not yet available. Most recently, HIV-1 entry has been understood much more and targeting viral entry based on chemokine receptors represents an interesting prospective. In this research highlight, we review the role of HIV-1 co-receptors-interacting proteins during chemokine receptor signal activation and assembly, as well as present new results about how they can regulate the replication of the virus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom